Health Trials

A Study to Explore the Role of Gut Flora in COVID-19 Infection

ConditionsGut MicrobiomeGastrointestinal MicrobiomeCOVIDCOVID-19Corona Virus InfectionCoronavirusCoronaviridae InfectionsCoronavirus 19Coronavirus-19COVID 19
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorProgenaBiome

About this trial

This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.

Eligibility criteria

Qualifiers

Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study

Male or female of 18 years of age or older

Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening

Disqualifiers

Refusal to sign informed consent form

History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.

Postoperative stoma, ostomy, or ileoanal pouch

Treatment with total parenteral nutrition

Trial design

Treatments tested in this trial

  • There is no intervention in this study

Treatment groups

250 Participants
are divided into 1 treatment group

Sponsors and collaborators

ProgenaBiome

Lead sponsor

Source ClinicalTrials.gov